In July, the Palacio Euskalduna hosted the celebration of the BIND 4.0 (Basque Industry 4.0 Accelerator Program) “Demo Day.” This is a disruptive event that gave the thirty-two technological startups participating in this acceleration program an opportunity to present their industrial projects of the future
The Digital Health market has been experiencing unprecedented growth. Just by looking at the investment volume of the past few years, we will notice that Digital Health startups have gone from attracting $5.5 billion in 2016 to a total funding volume of more than $8 billion in 2018. This represents more than an 80% growth rate in two years’ time.
Currently, there is a growing emphasis on complementing traditional clinical trials with studies based on Real-World Data (RWD). These studies have an enormous potential with the information provided by the individual patient (patient-reported outcome measures and patient-reported experience measures: PROMs and PREMs).
The increase in the use of new technology in the healthcare field has brought with it an important development in the collection, organization, and analysis of a lot of data (Big Data) about patients and their diseases. This generates an important concern related to the protection and security of personal data, along with their access.
Over the past few years, there has been a significant increase in the use of technologies in the healthcare environment, making up what is known today as Digital Health. Currently, Digital Health is the force for the change in how health is understood, as it has the potential for transforming how we manage diseases.
The 4th round of Emprende inHealth will support start-ups with solutions in the areas of cardiology, gynecology, intestinal health, telemedicine, and Real World Data. The six entrepreneurs who will participate in this 4th round will receive personalized assessment, training, and mentoring by Lilly.